Clinical Trials Logo

Mouth Diseases clinical trials

View clinical trials related to Mouth Diseases.

Filter by:

NCT ID: NCT04467541 Completed - Clinical trials for Hand Foot & Mouth Disease

Safety & Immunogenicity of Enterovirus Type 71 Vaccine in Healthy Adults and Children 6-71months

Start date: December 24, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

1. Burden: Hand-foot-and-mouth disease (HFMD) characterized by skin rash in extremities, mouth ulcer and fever among <5 years children.Primarily caused by Enterovirus- predominantly human Enterovirus (EV) 71 and Coxsackie virus (CoxA). Several large epidemics have been reported worldwide.Large Asia-Pacific epidemic-in China in 2008, approximately 490,000 infections and 126 deaths of children. EV71 contributes severe and fatal cases e.g. encephalitis.A recent outbreak of HFMD in Bhubaneswar, Odisha in India indicates there is a chance of HFMD outbreaks in Bangladesh. However there is not much report of HFMD from Bangladesh. 2. Knowledge gap: EV71 is most commonly transmitted via close person-to-person contact. Since there is no known effective treatment for HFMD and as the causative virus is highly contagious, hand washing is the best defense for prevention. However, asymptomatic or mild nature of the infection leads to ineffectiveness of public health interventions like hand washing. Thus the symptomatic management remains the mainstay of treatment strategy for HFMD as of now. EV71 vaccine, an inactivated vaccine, developed by Sinovac Biotech Ltd has shown satisfactory safety and effectiveness through Phase III trials conducted in various regions of mainland China, This new vaccine has the potential to significantly reduce suffering and death from EV71 disease in China. However, it is not assessed on Bangladeshi child. 3. Relevance: Due to the absence of effective public health strategy and proper treatment, the development of an effective vaccine may be the best way to control EV71 infection.

NCT ID: NCT04434014 Recruiting - Diet, Healthy Clinical Trials

Proper Nutrition And Its Relation To Oral Diseases In Covid -19 Era

Start date: June 8, 2020
Phase:
Study type: Observational

effect of proper diet and vitamins on the oral health and the regeneration of the taste and smell in Covid 19 patients

NCT ID: NCT04386421 Recruiting - Oral Disease Clinical Trials

A Comparison of Three Different Modalities in Improving Oral Hygiene

Start date: September 1, 2020
Phase: Phase 4
Study type: Interventional

The objective of the study is to compare effectiveness of OHI modalities a. verbal vs videographic material, b. Verbal vs plaque disclosing tablet and c. Videographic material vs plaque disclosing tablet over 3 months in adult orthodontic patients undergoing Fixed Appliance Treatment (FAT). Secondary objective of this study is to evaluate influence of three different modalities on patient cooperation and compliance towards orthodontic treatment.

NCT ID: NCT04295525 Not yet recruiting - Oral Diseases Clinical Trials

Carnosine Supplementation on Quantity/Quality of Oral Salivae.

PHoral
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to elucidate the mutual relationship between salivae characteristics and oral microbiome and to compare them with common oral disease; furthermore, by using specific bioinformatic tools to analyse the data, the potentials of Carnosine in preventing/treating oral diseases and its mechanism of action will be addressed by using quantitative proteomics.

NCT ID: NCT04273386 Completed - Systemic Sclerosis Clinical Trials

Mouth Handicap in Systemic Sclerosis

Start date: December 2, 2019
Phase: N/A
Study type: Interventional

In this study, it is aimed to investigate the mouth handicap in Systemic Sclerosis.

NCT ID: NCT04182932 Recruiting - Clinical trials for Hand, Foot and Mouth Disease

Safety and Immunogenicity of CJ-40010 in Healthy Subjects

Start date: December 2, 2019
Phase: Phase 1
Study type: Interventional

This study aims to evaluate the safety and immunogenicity of CJ-40010 after administration in healthy subjects

NCT ID: NCT04153266 Completed - Quality of Life Clinical Trials

Oral Epithelial Dysplasia Informational Needs Questionnaire

ODIN-Q
Start date: October 31, 2018
Phase:
Study type: Observational

Background: Oral epithelial dysplasia (OED) is a condition with an increased risk of oral cancer. Due to the current changes in the factors associated with these diseases (because of human papillomavirus), it is expected that those who have no history of smoking or alcohol, young (<50 years old), and white male would be commonly affected. Those individuals require a higher need for information, preferred a more active role in decision-making, and have a longer lifespan than older individuals. There remain no detailed studies of whether the informational needs delivered to patients with OED met their needs or indeed what information such patient may wish. A few tools are available to evaluate the IN of patients with head and neck disorders. However, the items of these instruments were dedicated to a particular disease (e.g. cancer) and hence are not applicable to be used for OED. Project aims: To evaluate the psychometric properties of the Oral Epithelial Dysplasia Informational Needs Questionnaire (ODIN-Q), developed and revised in the preliminary work for the proposed study, in a cohort of patients with OED. Timescale: 19 months. Clinical significance: This questionnaire can be useful in clinical practice. It could help to meet the patient's information needs and plan educational interventions for those showing unmet needs.

NCT ID: NCT04133584 Completed - Seasonal Influenza Clinical Trials

The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine

Start date: September 16, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the Immunogenicity and safety of the simultaneously vaccination of Inactivated Enterovirus 71 Vaccine (EV71) and seasonal influenza vaccine(SIV)

NCT ID: NCT04111432 Completed - Clinical trials for Hand, Foot and Mouth Disease

Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines

Start date: July 26, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the safety and immunogenicity of concomitant administration of EV71 vaccine with measles mumps, and rubella combined live attenuated vaccine/ encephalitis live attenuated vaccine.

NCT ID: NCT04074395 Completed - Mouth Diseases Clinical Trials

Oral and Maxillofacial Pathology in Pediatric Patients

Start date: October 2, 2019
Phase:
Study type: Observational

determination of the relative frequency of oral and maxillofacial pathological lesions among the Egyptian children and compare it with the global reports.